SUMMIT THERAPEUTICS INC.
Last · NasdaqGM$15.37+0.24 (+1.59%)live · yahoo · 43m ago
Vol 4.72M ≈ 72.58M
MA10MA20MA50
Market cap$12.26B797.7M sh
P/E · TTM-14.2fwd -13.2 · eps -1.08 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$12.07$29.23
Volume4.7Msession
Issuer
Legal nameSUMMIT THERAPEUTICS INC.
HQUnited States (US)
ListingUS SMMT
ISINUS86627T1088
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001599298
CIK0001599298
Websitewww.smmttx.com
Employees265
AddressSummit Therapeutics, Inc. 601 Brickell Key Drive 33131, Miami
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-02-23
From latest 10-K · 2026-02-23
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.7 years
- Accumulated Deficit High — Accumulated deficit / equity 348%
Upcoming earnings
MON.19OCT
10:00 PM UTC+2
Period
Sep 2026
Est. EPS
−$0.21
Est. revenue
54,000
Documents
FormReporting forFiledFlags
Showing 5 of 97 filings